Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Non Operating Income (2020 - 2025)

Journey Medical (DERM) has disclosed Non Operating Income for 6 consecutive years, with -$786000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 255.95% year-over-year to -$786000.0, compared with a TTM value of -$3.0 million through Sep 2025, down 1462.56%, and an annual FY2024 reading of -$934000.0, up 40.09% over the prior year.
  • Non Operating Income was -$786000.0 for Q3 2025 at Journey Medical, up from -$860000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $504000.0 in Q3 2024 and bottomed at -$4.4 million in Q4 2021.
  • Average Non Operating Income over 5 years is -$758684.2, with a median of -$578000.0 recorded in 2022.
  • Peak annual rise in Non Operating Income hit 239.61% in 2024, while the deepest fall reached 849.43% in 2024.
  • Year by year, Non Operating Income stood at -$4.4 million in 2021, then soared by 85.46% to -$634000.0 in 2022, then soared by 113.72% to $87000.0 in 2023, then plummeted by 849.43% to -$652000.0 in 2024, then fell by 20.55% to -$786000.0 in 2025.
  • Business Quant data shows Non Operating Income for DERM at -$786000.0 in Q3 2025, -$860000.0 in Q2 2025, and -$749000.0 in Q1 2025.